ZA906446B - Therapeutic agents for the treatment of peptic ulcer disease - Google Patents

Therapeutic agents for the treatment of peptic ulcer disease

Info

Publication number
ZA906446B
ZA906446B ZA906446A ZA906446A ZA906446B ZA 906446 B ZA906446 B ZA 906446B ZA 906446 A ZA906446 A ZA 906446A ZA 906446 A ZA906446 A ZA 906446A ZA 906446 B ZA906446 B ZA 906446B
Authority
ZA
South Africa
Prior art keywords
treatment
therapeutic agents
peptic ulcer
ulcer disease
alkyl
Prior art date
Application number
ZA906446A
Other languages
English (en)
Inventor
Toshizo Tanaka
Tanaka Toshizo
Shoryo Hayashi
Hayashi Shoryo
Yuko Morioka
Morioka Yuko
Ulrich Gebert
Gebert Ulrich
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of ZA906446B publication Critical patent/ZA906446B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA906446A 1989-08-16 1990-08-15 Therapeutic agents for the treatment of peptic ulcer disease ZA906446B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21018789 1989-08-16

Publications (1)

Publication Number Publication Date
ZA906446B true ZA906446B (en) 1991-05-29

Family

ID=16585226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906446A ZA906446B (en) 1989-08-16 1990-08-15 Therapeutic agents for the treatment of peptic ulcer disease

Country Status (18)

Country Link
US (1) US5109003A (xx)
EP (1) EP0413278B1 (xx)
JP (1) JP2977242B2 (xx)
KR (1) KR910004620A (xx)
AT (1) ATE144900T1 (xx)
AU (1) AU624987B2 (xx)
CA (1) CA2023310A1 (xx)
DD (1) DD298051A5 (xx)
DE (1) DE69029069T2 (xx)
DK (1) DK0413278T3 (xx)
ES (1) ES2094132T3 (xx)
GR (1) GR3021569T3 (xx)
HU (1) HU207518B (xx)
IE (1) IE902954A1 (xx)
IL (1) IL95377A (xx)
NZ (1) NZ234896A (xx)
PT (1) PT95007A (xx)
ZA (1) ZA906446B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5354756A (en) * 1993-01-12 1994-10-11 Cell Therapeutics, Inc. Olefin-substituted long chain xanthine compounds
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IL106861A (en) * 1986-12-31 1997-02-18 Hoechst Roussel Pharma Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
DK0413278T3 (da) 1997-04-07
EP0413278A3 (en) 1992-05-06
GR3021569T3 (en) 1997-02-28
DE69029069T2 (de) 1997-04-10
NZ234896A (en) 1993-10-26
PT95007A (pt) 1991-04-18
ES2094132T3 (es) 1997-01-16
CA2023310A1 (en) 1991-02-17
JP2977242B2 (ja) 1999-11-15
DE69029069D1 (de) 1996-12-12
IL95377A (en) 1994-08-26
KR910004620A (ko) 1991-03-29
IL95377A0 (en) 1991-06-30
HUT54688A (en) 1991-03-28
IE902954A1 (en) 1991-02-27
HU207518B (en) 1993-04-28
US5109003A (en) 1992-04-28
AU6101890A (en) 1991-02-21
DD298051A5 (de) 1992-02-06
AU624987B2 (en) 1992-06-25
ATE144900T1 (de) 1996-11-15
JPH03163019A (ja) 1991-07-15
EP0413278B1 (en) 1996-11-06
EP0413278A2 (en) 1991-02-20
HU905000D0 (en) 1991-01-28

Similar Documents

Publication Publication Date Title
IE860222L (en) Imidazole derivatives.
EP0288969A3 (en) Antiulcer composition
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
AU2853889A (en) Therapeutic agents for the treatment of peptic ulcer disease
ZA906446B (en) Therapeutic agents for the treatment of peptic ulcer disease
AU6063298A (en) Benzamide derivative, anti-ulcer drug, and antibacterial drug
GB8706662D0 (en) Anti-arrhythmia agents
DE3371909D1 (en) 7-alpha-acylthio-15,16-methylene-3-oxo-17-alpha-pregna-1,4-diene-21,17-carbolactones, their preparation and use as medicinal agents
AU1669288A (en) Antidiabetic composition comprising 7-thiaprostaglandin e1 or its derivative
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
AU8292787A (en) Fluorine-containing macrolide compounds and their use